Genome-wide association studies revealed that several risk alleles of genes such as PNPLA3 and GCKR are associated with the prevalence of NAFLD/NASH [[4], [5], [6]]. Here, PNPLA3 is linked to metabolic dysfunction-associated steatotic liver disease.